Study guide
1.5 General Pathology, Inflammation & Immunity Concepts
National Board Dental Hygiene Examination NBDHE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Head, Neck & Dental Anatomy, Histology & Embryology
1.1 Head & Neck Cranial Nerves, Osteology & Musculature 1.2 Tooth Morphology, Occlusion & Root Anatomy 1.3 Tooth Development, Histology & Embryology 1.4 Oral Physiology, Salivary Gland Function & TMJ Dynamics 1.5 General Pathology, Inflammation & Immunity Concepts
2 Chapter 2: Oral Pathology, Microbiology & Biofilm Ecology
2.1 Oral Mucosal Lesions, Soft Tissue & Salivary Pathology 2.2 Hard Tissue Anomalies, Cysts, Neoplasms & Radiographic Pathology 2.3 Periodontal Pathology, Plaque Biofilm Ecology & Microbiology 2.4 Cariology, Demineralization Mechanics & Fluoride Chemistry 2.5 Systemic Disease Manifestations & Oral Cancer Risk Factors 2.6 Genetic Conditions, Immunopathology & Diagnostic Biopsy Protocols
3 Chapter 3: Dental Pharmacology, Biochemistry & Nutrition
3.1 Autonomic Drugs, Cardiovascular & Respiratory Pharmacology 3.2 Analgesics, Opioids, NSAIDs & Central Nervous System Agents 3.3 Antimicrobial Therapy, Antibiotic Prophylaxis & Antivirals/Antifungals 3.4 Nutritional Biochemistry, Vitamins, Minerals & Dietary Analysis 3.5 Endocrine Pharmacology, Diabetic Care & Bone Metabolism Agents 3.6 Special Population Pharmacotherapeutics & Drug Interactions
4 Chapter 4: Patient Assessment, Risk Evaluation & Radiographic Interpretation
4.1 Health History Review, ASA Physical Status & Medical Risk Assessment 4.2 Comprehensive Extraoral/Intraoral Examination & Soft Tissue Inspection 4.3 Periodontal Assessment, Probing Techniques & Furcation Classification 4.4 Hard Tissue Examination, Caries Detection & Restorative Evaluation 4.5 Dental Radiography Principles, Physics, Technique & Radiation Safety 4.6 Radiographic Interpretation, Normal Landmarks & Pathologic Artifacts
5 Chapter 5: Periodontal Therapy, Instrumentation & Preventive Services
5.1 Periodontal Disease Etiology, Pathogenesis & Host Response 5.2 Non-Surgical Periodontal Therapy (NSPT) & Scaling/Root Planing (SRP) 5.3 Dental Hygiene Instrumentation, Ergonomics & Sharpness Maintenance 5.4 Preventive Oral Health Agents, Dentifrices, Rinses & Remineralization 5.5 Surgical Periodontal Therapy Overview & Maintenance Protocols 5.6 Patient Motivation, Behavioral Change & Oral Hygiene Instruction 5.7 Care Planning for Special Needs, Medically Compromised & Geriatric Patients
6 Chapter 6: Local Anesthesia Administration, Dental Materials & Special Care
6.1 Local Anesthesia Pharmacology, Neurophysiology & Vasoconstrictors 6.2 Injection Techniques, Anatomical Landmarks & Nerve Blocks 6.3 Local Anesthesia Complications, Toxicity & Nitrous Oxide Sedation 6.4 Dental Materials Chemistry, Impression Media & Restorative Auxiliaries 6.5 Pit & Fissure Sealants, Polishers & Biomaterial Biocompatibility 6.6 Orthodontic, Endodontic, Pediatric & Implant Patient Care
7 Chapter 7: Infection Prevention, OSHA/CDC Protocols & Medical Emergencies
7.1 Infection Control Principles, Transmission Pathways & Standard Precautions 7.2 Sterilization Methods, Biological Monitoring & Chemical Disinfection 7.3 OSHA Bloodborne Pathogens Standard, HazCom & Regulatory Compliance 7.4 Medical Emergency Recognition, CPR/AED & Protocol Management 7.5 Pharmacological Emergency Interventions & Airway Management 7.6 Instrument Processing Safety, Waste Management & Post-Exposure Protocols
8 Chapter 8: Community Oral Health, Epidemiology & Evidence-Based Research
8.1 Dental Public Health Principles, Community Assessment & Needs Analysis 8.2 Oral Epidemiology Indices: DMF, GI, PI, CPITN, Debris & Calculus Indices 8.3 Community Water Fluoridation Standards, Cost-Benefit & Public Health Policy 8.4 Evidence-Based Decision Making, Research Design, Control Groups & Sampling 8.5 Biostatistics in Dental Research: Mean, Median, P-values, Sensitivity & Specificity
9 Chapter 9: Integrated Case-Based Scenarios, Patient Cases & Professional Ethics
9.1 Case Scenario 1: Complex Periodontal Patient with Systemic Conditions 9.2 Case Scenario 2: Pediatric & Adolescent Preventive Management 9.3 Case Scenario 3: Medically Compromised & Special Needs Geriatric Patient 9.4 Case Scenario 4: Oral Pathology Identification & Interprofessional Referral 9.5 Professional Ethics, Jurisprudence & Dental Hygiene Practice Acts 9.6 Risk Management, Informed Consent & Interprofessional Collaboration
1.5 General Pathology, Inflammation & Immunity Concepts
Key Takeaways Explain This Topic AI
Acute inflammation involves immediate transient vasoconstriction followed by vasodilation (hyperemia) and increased vascular permeability leading to exudative edema.
Leukocyte extravasation proceeds through margination, rolling (selectins), adhesion (integrins), diapedesis (PECAM-1), and chemotaxis (C5a, LTB4, IL-8).
The complement cascade generates C3a/C5a (anaphylatoxins), C5a (neutrophil chemotaxis), C3b (opsonization), and C5b–C9 (membrane attack complex cell lysis).
Hypersensitivity reactions are categorized into Types I (IgE/anaphylaxis), II (cytotoxic/pemphigus vulgaris), III (immune complex/SLE), and IV (cell-mediated T-cell/contact dermatitis).
Autoimmune oral diseases include Pemphigus Vulgaris (desmoglein-3 antibodies, intraepithelial split, Nikolsky positive) and Mucous Membrane Pemphigoid (hemidesmosome antibodies, subepithelial split).
Last updated: July 2026
General Pathology, Inflammation & Immunity Concepts
NBDHE Core Concept: Understanding the vascular and cellular sequences of inflammation, chemical mediator cascades, complement activation, hypersensitivity mechanisms, and autoimmune pathology is essential for recognizing oral mucosal diseases and understanding periodontal destruction.
1. Vascular Response & Hemodynamic Events in Acute Inflammation
Acute inflammation is the immediate, non-specific vascular and cellular response to tissue injury or pathogen invasion. The vascular sequence occurs in predictable hemodynamic steps: Injury ──► Transient Vasoconstriction ──► Vasodilation (Hyperemia) ──► Permeability Increase ──► Exudation & Stasis
Hemodynamic Sequence
Transient Vasoconstriction: Lasts only seconds; neurogenic reflex protecting against blood loss.
Arteriolar Vasodilation: Induced by vasoactive mediators ( histamine , bradykinin , prostaglandins ). Causes increased blood flow to the injured area ( active hyperemia ), responsible for two cardinal signs: Rubor (redness) and Calor (heat) .
Increased Vascular Permeability: Endothelial cells contract, creating intercellular gaps in post-capillary venules. Protein-rich fluid ( exudate ) escapes into extravascular tissue, causing Tumor (swelling/edema) .
Stasis & Hemoconcentration: Loss of fluid concentrates red blood cells in vessels, slowing blood flow and allowing leukocytes to marginate along vessel walls.
Pain & Loss of Function: Dolor (pain) is triggered by pressure from edema and direct nerve stimulation by bradykinin and prostaglandin E2 ( P G E 2 PGE_2 PG E 2 ) . Combined symptoms result in Functio Laesa (loss of function) .
2. Cellular Events, Extravasation & Phagocytosis
The cellular phase is dominated by Polymorphonuclear Neutrophils (PMNs) during the first 24–48 hours, followed by Macrophages .
Leukocyte Extravasation Cascade
Margination: PMNs move from central axial stream to peripheral vessel walls.
Rolling & Pavementing: PMNs roll along endothelium via weak, transient binding of Selectins (E-selectin, P-selectin on endothelium; L-selectin on PMN).
Firm Adhesion: PMNs firmly bind to endothelial cell surface via Integrins (LFA-1, MAC-1 on PMN binding to ICAM-1 and VCAM-1 on endothelium).
Transmigration (Diapedesis): PMNs squeeze through endothelial junctional gaps into tissue spaces, mediated by PECAM-1 (CD31) .
Chemotaxis: Unidirectional migration of PMNs along a chemical gradient toward the injury site. Key chemoattractants include C5a , Leukotriene B4 ( L T B 4 LTB_4 L T B 4 ) , Interleukin-8 (IL-8) , and bacterial N-formyl peptides.
Phagocytosis & Intracellular Killing
Opsonization: Pathogens are coated with Opsonins ( IgG antibodies and C3b complement fragments) to facilitate recognition by PMN surface receptors.
Engulfment & Killing: PMN extends pseudopods to form a phagosome, which fuses with lysosome forming a phagolysosome .
Oxygen-Dependent Killing: Most potent mechanism; mediated by Myeloperoxidase (MPO) producing hypochlorous acid ( H O C l HOCl H OCl ) from hydrogen peroxide ( H 2 O 2 H_2O_2 H 2 O 2 ) and chloride.
Oxygen-Independent Killing: Mediated by lysozyme, defensins, and lactoferrin.
3. Acute vs Chronic Inflammation & Granulomatous Patterns
- Characteristic Acute Inflammation Chronic Inflammation
- Onset & Duration Immediate onset; short duration (days to weeks) Insidious onset; prolonged (months to years)
- Predominant Cells PMN Neutrophils Macrophages , Lymphocytes , Plasma cells
- Vascular Response Prominent vasodilation & fluid exudation Angiogenesis (neovascularization) & fibrosis
Tissue Outcome Resolution, abscess formation, or chronic transition Tissue destruction, repair by scarring (fibrosis)
Granulomatous Inflammation
A specialized pattern of chronic inflammation characterized by microscopic aggregates of epithelioid histiocytes (modified macrophages) surrounded by a collar of lymphocytes and multinucleated Langhans giant cells (fused macrophages with horseshoe ring nuclei). Classic examples include tuberculosis , sarcoidosis , foreign body reactions, and deep fungal infections.
- 4. Chemical Mediators & Complement System
- Key Inflammatory Mediators
Vasoactive Amines: Histamine (released by mast cells and basophils; causes immediate vasodilation and vascular permeability).
Arachidonic Acid Metabolites:
Cyclooxygenase (COX) Pathway: Produces Prostaglandins ( P G E 2 PGE_2 PG E 2 causes pain and fever; T X A 2 TXA_2 TX A 2 causes vasoconstriction/platelet aggregation). NSAIDs and aspirin inhibit COX-1/COX-2.
Lipoxygenase (LOX) Pathway: Produces Leukotrienes ( L T B 4 LTB_4 L T B 4 causes PMN chemotaxis; L T C 4 LTC_4 L T C 4 , L T D 4 LTD_4 L T D 4 , L T E 4 LTE_4 L T E 4 cause bronchospasm and increased permeability).
Cytokines: TNF-alpha and IL-1 drive systemic acute phase response (fever, leukocytosis).
Kinins: Bradykinin causes potent vasodilation, non-vascular smooth muscle contraction, and pain.
The Complement Cascade
A system of plasma proteins circulating in inactive forms, activated via three pathways:
Classical Pathway: Triggered by antigen-antibody complexes (IgG or IgM bound to antigen).
Alternative Pathway: Triggered directly by bacterial endotoxins (LPS) and cell wall polysaccharides.
Lectin Pathway: Triggered by mannose-binding lectin binding microbial carbohydrates.
Essential Complement Cleavage Products
C3a & C5a (Anaphylatoxins): Trigger mast cell degranulation, releasing histamine.
C5a: Potent chemotactic factor attracting PMNs to injury site.
C3b: Major opsonin coating microbes for phagocytosis.
C5b–C9 (Membrane Attack Complex / MAC): Forms transmembrane pores in bacterial cell walls, causing osmotic lysis.
5. Hypersensitivity Reactions (Types I–IV) & Autoimmune Oral Disease
Coombs and Gell classified hypersensitivity reactions into four immunological types:
Type Mechanism Key Mediators Clinical Examples & Oral Manifestations
Type I (Immediate) IgE cross-linking on mast cells/basophils; degranulation IgE, Histamine, Leukotrienes Anaphylaxis, allergic asthma, angioedema, latex allergy
Type II (Cytotoxic) Antibody (IgG/IgM) binds cell surface antigen; complement/ADCC IgG, IgM, Complement Pemphigus vulgaris, mucous membrane pemphigoid, RH incompatibility
Type III (Immune Complex) Circulating antigen-antibody complexes deposit in tissues IgG, IgM, Immune complexes Systemic Lupus Erythematosus (SLE), serum sickness, Arthus reaction
Type IV (Delayed) Cell-mediated; T-lymphocytes (CD4+/CD8+) activate macrophages T-Cells (NO antibodies!) Contact dermatitis (latex, nickel), Mantoux TB test, graft rejection
Autoimmune Oral Mucosal Manifestations
Pemphigus Vulgaris: Autoantibodies target Desmoglein-3 (intraepithelial desmosomes). Causes intraepithelial acantholysis (suprabasal split). Clinical presentation: fragile bullae that rupture into painful erosions; positive Nikolsky sign (sloughing of tissue upon gentle pressure); Tzanck cells on cytology.
Mucous Membrane Pemphigoid (Cicatricial): Autoantibodies target hemidesmosomes (BP180 in basement membrane). Causes subepithelial split (entire epithelium detaches from lamina propria). Clinical presentation: thick-walled bullae, desquamative gingivitis , negative Nikolsky sign, scarring of ocular and oral mucosa.
Sjögren's Syndrome: Autoimmune destruction of exocrine glands. Triad of xerostomia , keratoconjunctivitis sicca (dry eyes) , and rheumatoid arthritis. Diagnostic markers: anti-SSA (Ro) and anti-SSB (La) autoantibodies.